Related Experiment Video
Updated: Jun 3, 2025
09:22
A Method for Remotely Silencing Neural Activity in Rodents During Discrete Phases of Learning
Published on: June 22, 2015
14.6K
What should constitute a control condition in psychedelic drug trials?
Luana Colloca1, Maurizio Fava2
1Department of Pain and Translational Symptom Science, Placebo Beyond Opinions Center, University of Maryland School of Nursing, Baltimore, MD, USA.
Nature. Mental Health
|January 9, 2025
Summary
Psychedelic research for neuropsychiatric disorders needs robust trial designs. This study explores placebo effects and control conditions to ensure reliable therapeutic outcome assessments beyond expectations.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Trials
Background:
- Growing interest in psychedelic compounds like psilocybin, LSD, and MDMA for treating neuropsychiatric disorders.
- Challenges in psychedelic research include designing effective placebo controls to differentiate drug effects from expectation bias.
Purpose of the Study:
- To explore the neurobiology of placebo and expectation effects in psychedelic trials.
- To examine methodological considerations for selecting appropriate control conditions.
- To propose new directions for enhancing trial validity and regulatory science.
Main Methods:
- Review of neurobiological mechanisms underlying placebo and expectation effects.
- Analysis of various control conditions used in psychedelic clinical trials, including their pros and cons.
- Discussion of strategies to improve blinding and reduce bias.
Main Results:
- Placebo and expectation effects can confound the interpretation of psychedelic therapeutic benefits.
- The selection of control conditions is critical for disentangling drug-specific effects from non-specific effects.
- Current methodologies may not adequately control for expectancy.
Conclusions:
- Improving control conditions and blinding in psychedelic trials is essential for reliable research.
- Addressing methodological limitations will enhance the scientific rigor of psychedelic therapeutics.
- This work aims to advance the regulatory science for psychedelic treatments.
More Related Videos
Related Concept Videos
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:22CNS Stimulants: Psychedelic Agents
123
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
123
01:27Hallucinogens and Psychedelics
156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
01:13Controls in Experiments
6.9K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
6.9K
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
119
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
119